Marinus Pharmaceuticals Inc
(NASDAQ : MRNS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-0.41%154.450.4%$169.66m
PRGOPerrigo Co. Plc
0.13%85.046.4%$136.67m
VRXValeant Pharmaceuticals International, Inc.
0.50%14.0814.2%$136.47m
ICPTIntercept Pharmaceuticals, Inc.
-0.34%61.3822.1%$118.18m
MNKMallinckrodt Plc
1.24%35.2617.7%$87.64m
PTLAPortola Pharmaceuticals, Inc.
-0.78%53.708.9%$72.48m
UTHRUnited Therapeutics Corporation
3.57%118.6913.9%$70.87m
ALRAlere Inc.
-0.17%50.272.7%$70.38m
PRXLPAREXEL International Corporation
0.03%88.027.9%$63.38m
SAGESAGE Therapeutics, Inc.
0.14%62.9911.9%$59.31m
JAZZJazz Pharmaceuticals Plc
1.16%149.612.2%$59.01m
MDCOMedicines Company
1.75%36.0622.3%$56.50m
CTLTCatalent Inc
-0.03%40.752.8%$53.12m
SUPNSupernus Pharmaceuticals, Inc.
0.96%39.386.5%$41.07m
ADMSAdamas Pharmaceuticals, Inc.
-0.47%21.2717.2%$39.04m

Company Profile

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of neuropsychiatric therapeutics. Its clinical stage drug candidate, ganaxolone, is a novel synthetic small molecule that is an analog of allopregnanolone, a natural occurring neurosteriod produced by the human body, which modulates gamma-aminobutyric acid a neurotransmitter in the brain. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.